San Diego-primarily based Viking Therapeutics marked by itself as a serious competitor inside the weight loss drug market in February right after revealing promising details from the mid-stage demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when given being a weekly injection and in March the c

Even businesses with candidates previously while in the afterwards phases of tests remain about to need quite a few several years to collect and approach the data and, ought to items pan out, time to work with regulators to protected approval. Launching the drug is another matter completely and shoring up plenty of supplies has confirmed complicate